APP and Alzheimer disease: Studies showed that Astragalus polysaccharide alleviated cognitive impairment and β-amyloid accumulation in APP/PS1 mice [15] and Astragaloside IV ameliorated cognitive impairment and neuroinflammation in an oligomeric Aβ induced AD mice model [16].